Benchmark to sell genetics business
2024-11-27T12:40:00
Benchmark Holdings has announced the sale of its genetics arm to Starfish Bidco to streamline operations and concentrate on its advanced nutrition and health business areas
The sale, which is expected to complete during the first quarter of 2025 subject to shareholder and regulatory approval, represents an enterprise value of up to £260 million.
Proceeds from the sale will be used to return capital to shareholders and to reduce company debt.